YANIKLER
Dead / Cancelled — Cancelled — Section 8 (as of 24 Nov 2017)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85009184
- Registration number
- 3947037
- Mark type
- Stylized text
- Filed
- 08 Apr 2010
- Published for opposition
- 01 Feb 2011
- Registered
- 19 Apr 2011
- Attorney of record
- Adrienne L. White
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical and veterinary preparations, namely, medicines, vaccines, and serums for the testing, prevention, treatment and diagnosis of tumor precursors, benign and malignant tumors, in particular, warts, genital warts, neuronal tumors, glioma, astrocytoma, colon carcinoma, ovarian carcinoma, cervical cancer, prostate carcinoma, basal cell carcinoma, squamous cell carcinoma, melanoma, kaposi's sarcoma, breast cancer, head and neck carcinomas, hepatocellular carcinoma, bronchial carcinoma, pancreatic tumours and renal tumours, autoimmune disorders, in particular rheumatoid arthritis, polyarthritis, crohn's disease, lupus erythematosus and multiple sclerosis, neurodegenerative disorders, in particular alzheimer's disease, huntington's disease, multiple sclerosis, parkinson's disease, schizophrenia, transmissible spongiform encephalopathy, bovine spongiform encephalopathy and/or creutzfeldt-jakob disease, rheumatic disorders, in particular rheumatoid arthritis, polychondritis, bechterew's disease, fibromyalgia and lupus erythematodes, allergic diseases, in particular allergies, allergic rhinitis, hay fever, asthma, atopic eczema and insect sting allergies, cardiovascular disorders, in particular hyperlipidaemia, coronary artery disorders, cardiac insufficiency, high blood pressure and obesity, skin diseases, in particular warts, genital warts, bowen's disease, actinic keratosis, seborrhoeic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and herpes, infectious diseases, in particular viral infections, bacterial infections, parasitic infections and/or fungal infections, and ophthalmic disorders, in particular age-dependent macular degeneration, glaucoma and retinoblastoma; all of the above consisting of low-molecular active substances, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, t-cell proteins, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-type particles and plant extracts, in particular for oral, topical, intravenous and subcutaneous administration
Owner
- MediGene AG, Planegg/Martinsried, DE
- MediGene AG, Planegg/Martinsried, DE
- MediGene AG, Planegg/Martinsried, DE
Prior registrations
Prosecution history
- 24 Nov 2017 — CANCELLED SEC. 8 (6-YR)
- 19 Apr 2011 — REGISTERED-PRINCIPAL REGISTER
- 01 Feb 2011 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Feb 2011 — PUBLISHED FOR OPPOSITION
- 29 Dec 2010 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 22 Dec 2010 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Dec 2010 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Dec 2010 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Dec 2010 — ASSIGNED TO LIE
- 29 Nov 2010 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 May 2010 — NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 29 May 2010 — EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
- 29 May 2010 — EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
- 27 May 2010 — ASSIGNED TO EXAMINER
- 13 Apr 2010 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED